BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33647880)

  • 21. Inflammatory activation biomarker profile after marathon running and its impact on cardiovascular stress in amateur middle-aged male runners.
    Kosowski M; Swoboda K; Chmura J; Kustrzycka-Kratochwil D; Todd JA; Jankowska EA; Reczuch K; Ponikowski P
    Adv Clin Exp Med; 2023 Apr; 32(4):441-448. PubMed ID: 36398372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) to competitive endurance exercise in recreational athletes.
    Vidotto C; Tschan H; Atamaniuk J; Pokan R; Bachl N; Müller MM
    Int J Sports Med; 2005 Oct; 26(8):645-50. PubMed ID: 16158369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance trends and cardiac biomarkers in a 30-km cross-country race, 1993-2007.
    Aagaard P; Sahlén A; Braunschweig F
    Med Sci Sports Exerc; 2012 May; 44(5):894-9. PubMed ID: 22005746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does a run/walk strategy decrease cardiac stress during a marathon in non-elite runners?
    Hottenrott K; Ludyga S; Schulze S; Gronwald T; Jäger FS
    J Sci Med Sport; 2016 Jan; 19(1):64-8. PubMed ID: 25467199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
    Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular stress biomarker assessment of middle-aged non-athlete marathon runners.
    Kosowski M; Młynarska K; Chmura J; Kustrzycka-Kratochwil D; Sukiennik-Kujawa M; Todd JA; Jankowska EA; Banasiak W; Reczuch K; Ponikowski P
    Eur J Prev Cardiol; 2019 Feb; 26(3):318-327. PubMed ID: 30744458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging of myocardial injury and ventricular torsion after marathon running.
    Hanssen H; Keithahn A; Hertel G; Drexel V; Stern H; Schuster T; Lorang D; Beer AJ; Schmidt-Trucksäss A; Nickel T; Weis M; Botnar R; Schwaiger M; Halle M
    Clin Sci (Lond); 2011 Feb; 120(4):143-52. PubMed ID: 20815809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnitude, reproducibility, and association with baseline cardiac function of cardiac biomarker release in long-distance runners aged > or =55 years.
    Sahlén A; Winter R; Lind B; Jacobsen PH; Ståhlberg M; Marklund T; Fux T; Svensson J; Braunschweig F
    Am J Cardiol; 2008 Jul; 102(2):218-22. PubMed ID: 18602525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of myeloperoxidase in conjunction with cardiac-specific markers after marathon running.
    Melanson SE; Green SM; Wood MJ; Neilan TG; Lewandrowski EL
    Am J Clin Pathol; 2006 Dec; 126(6):888-93. PubMed ID: 17074690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of the slopes of ST2 and galectin-3 during marathon and ultratrail running compared to a control group.
    Le Goff C; Kaux JF; Farre Segura J; Stojkovic V; Ancion A; Seidel L; Lancellotti P; Cavalier E
    Clin Chem Lab Med; 2020 Jan; 58(2):314-321. PubMed ID: 31622239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.
    Chen JR; Wang Q; Wu W; Zhang SJ
    Clin Interv Aging; 2019; 14():81-90. PubMed ID: 30643397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
    Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
    Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults.
    Chang CL; Mills GD; Karalus NC; Jennings LC; Laing R; Murdoch DR; Chambers ST; Vettise D; Tuffery CM; Hancox RJ
    PLoS One; 2013; 8(5):e62612. PubMed ID: 23667500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal pro-B-type natriuretic peptide and cardiac troponin T in non-immune hydrops.
    Lee SM; Jun JK; Kim SA; Kang MJ; Song SH; Lee J; Park CW; Park JS
    J Obstet Gynaecol Res; 2016 Apr; 42(4):380-4. PubMed ID: 26787625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac fatigue in long-distance runners is associated with ventricular repolarization abnormalities.
    Sahlén A; Rubulis A; Winter R; Jacobsen PH; Ståhlberg M; Tornvall P; Bergfeldt L; Braunschweig F
    Heart Rhythm; 2009 Apr; 6(4):512-9. PubMed ID: 19324313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
    J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
    Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.